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Abstract Thyrsiferyl 23-acetate (TF23A), a cytotoxic compound from marine red alga, has been shown to potently and specifically inhibit 
serinelthreonine protein phosphatase 2A (PPZA) with IC,, values of 4-16 PM, depending on the enzyme concentration. TF23A did not affect activity 
of protein phosphatase 1 (PPl), 2B (PP2B), 2C (PP2C), or protein tyrosine phosphatases (PTP) up to 1 mM. It inhibited PPZA activity in a crude 
extract of a human T cell line, Jurkat cell, as well as the purified catalytic subunit. Thus, TF23A proved to be a novel useful probe for clearly 
distinguishing the activity of PP2A from those of the other protein phosphatases in crude cell extracts and identification of cellular processes that 
are regulated by PP2A. 
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1. Introduction 
Okadaic acid (OA), a polyether fatty acid isolated from ma- 
rine sponges as a cytotoxic compound [ 11, has been reported to 
have a potent inhibitory effect on serine/threonine protein 
phosphatase PPl and PP2A [2]. Another polyether containing 
squalene carbon skeleton, thyrsiferyl 23-acetate (TF23A), was 
isolated from the red alga L. obtusa [3]. This compound, like 
OA, showed strong cytotoxicity against mammalian cells, sug- 
gesting that TF23A might also be an inhibitor of protein 
phosphatases. 
A number of substances have an inhibitory effect on serinel 
threonine protein phosphatase activities, such as calyculin A 
[4], tautomycin [5,6], microcystin-LR [6,7], and nodularin [9]. 
However, there had been no known inhibitor which affects only 
PP2A until now. All these substances show a strong inhibitory 
effect towards both PPl and PP2A, and some of them inhibit 
PP2B to a lesser extent. These facts make it difficult to study 
the specific function of each molecular species of protein phos- 
phatase. 
We report here that TF23A is a potent and specific inhibitor 
of PP2A but has no effect on PPl, PP2B, PP2C, or PTP. 
2. Materials and methods 
2.1. Materials 
Thyrsiferyl23-acetate (TF23A) prepared from the red alga L. obtusa 
as previously described [3], was dissolved in dimethyl sulfoxide at 20 
mM. Okadaic acid was a generous gift from Dr. Tsukitani (Fujisawa 
Chemical Co., Japan). Catalytic subunits of PPl and PP2A [lo], 
phosphorylase a [l 11, phosphorylase kinase [12], and inhibitor-2 [13] 
were prepared from rabbit skeletal muscle as previously described. 
PPZC [14] and tyrosine kinases (151 were partially purified from rat liver 
and spleen, respectively. Myelin basic protein (MBP), histone (type 
HA-S), lysozyme, and catalytic subunit of bovine heart CAMP-depend- 
ent protein kinase were obtained from Sigma Chemical Co. (St. Louis, 
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MO). Catalytic subunit of bovine brain PP2B was from Upstate 
Biotechnology (Lake Placid, NY). [T-~*P]ATP was purchased from 
Dupont/NEN Research Products (Boston, MA). 
2.2. Preparation of cell extracts 
The human acute T lymphoblasticleukemia cell line, Jurkat cells, was 
maintained in RPMI-1640 medium supplemented with 10% fetal calf 
serum, 2 mM L-glutamine, 0.05 mM 2-mercaptoethanol. The cells were 
lysed at a concentration of 2 x lO’/ml in cold lysis buffer containing 50 
mM Tris-HCl (pH 7.0), 250 mM sucrose, 2 mM EDTA, 2 mM EGTA, 
0.1 mM PMSF, 0.5 mM TPCK, 1 mM benzamidine, 4pg/ml leupeptin, 
and 1 .O% (w/v) Nonidet P-40. The lysates were centrifuged at 8,000 x g 
for 10 min and the resulting supematants were used as cell extracts. 
2.3. Preparation of ‘ZP-labelled proteins and phosphatase assays 
32P-Labelled phosphorylase a was prepared by using phosphorylase 
kinase [16]. “P-Labelled MBP and [32P]histone were prepared by using 
CAMP-dependent kinase [17]. ‘2P-Labelled RCM-lysozyme was pre- 
pared by using rat spleen tyrosine kinases [18]. Phosphatase assays were 
performed as previously described [19]. PPl and PP2A were assayed in 
the absence of divalent cations by using 10 PM [“Plphosphorylase a, 
5 PM [“PJMBP or 5 PM [“Plhistone as substrate. PP2B was assayed 
in the presence of 2 mM CaCl, and 3 PM calmodulin by using 5 PM 
[“P]MBP [20]. PP2C was assayed in the presence of 10 mM MgC12 by 
using 5 PM [‘*P]histone [19]. Tyrosine phosphatase activity in cell ex- 
tracts was measured by using 30pM [3ZP]RCM-lysozyme [18]. One unit 
(U) of each activity was defined as the amount of enzyme that catalyzes 
the release of 1 pmol of phosphate per min. 
3. Results and discussion 
Thyrsiferyl23-acetate (TF23A) was purified from the marine 
red alga Lauren& obtusa collected from Teuri Island, 
Hokkaido, Japan (Fig. 1) [3]. 
The dephosphorylation of [32P]MBP by the catalytic subunit 
of PP2A from rabbit skeletal muscle was potently inhibited by 
TF23A. In the standard assay, PP2A was completely inhibited 
at 100 PM (Fig. 2). On the other hand, TF23A had no effect 
on the activity of purified PPl, PP2B or PP2C, or PTP activity 
in a crude cell extract from Jurkat cells. The inhibition of PPZA 
by TF23A was also observed when other phosphoproteins, 
[32P]histone or [32P]phosphorylase a, were used as substrates 
(Fig. 3). The concentration required for 50% inhibition (IQ 
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Fig. 1. Structure of thyrsiferyl 23-acetate [3]. 
of PP2A depended on the enzyme concentration in the assays. 
As shown in Fig. 3A, a lo-fold dilution of PP2A caused the 
apparent ICso to change from 16 to 4 PM with [32P]MBP as 
substrate. Similar decreases in IC,, values were observed with 
[3ZP]histone and [32P]phosphorylase a (Fig. 3B and C). This 
‘shift’ in IC,, has been commonly observed with okadaic acid 
[21], tautomycin [5] microcystin-LR [7,8], and nodularin [9], as 
previously reported. 
To determine whether the potency of TF23A on native forms 
of PP2A is comparable to that on purified catalytic subunit, we 
examined the effect of TF23A on protein phosphatase activity 
in a crude cell extract. Fig. 4 shows the inhibitory effects of OA 
and TF23A in the crude extract from Jurkat cells. When MBP 
was used as the substrate, OA potently inhibited the divalent 
cation-independent phosphatase (PPl and PP2A) activity in the 
crude cell extract, causing 90% inhibition at 1 PM (Fig. 4A). 
The dose-inhibition curve by OA appears to be biphasic, the 
first inhibition at 1 pM-1 nM and the second at 1 nM-1OpM. 
The IC,, vales for the first and second inhibitions were 35 pM 
and 24 nM, respectively. The values are almost the same with 
those obtained by using the purified catalytic subunits of PP2A 
and PPl, respectively (data not shown), and those reported 
previously [9,21], suggesting that the extent of the first and 
second inhibitions represent activities of PP2A and PPl, respec- 
tively. On the other hand, TF23A (Fig. 4B) showed monopha- 
sic inhibition curves, reaching 60% inhibition of the total activ- 
ity at above 100 ,uM. The IC,, value for the TF23A inhibition 
was 8 PM at a SO-fold dilution of extract, and the value changed 
depending on dilution of the crude cell extract (data not shown) 
like that for the PP2A catalytic subunit. To determine whether 
the activity inhibited by TF23A is that of PP2A, additive effects 
of the PPl-specific inhibitor 2, TF23A, and OA on 
phosphatases (PPl and PP2A) in the crude cell extract were 
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Fig. 2. Effect of TF23A on various protein phosphatases. The catalytic 
subunit of PPl (0) was assayed at 0.015 mu/ml by using 
[‘2P]phosphorylase a as the substrate. Assay for PP2A (0) and PP2B (A) 
catalytic subunits were at 0.015 mu/ml and 0.09 mu/ml, respectively, 
with [“PIMBP. Rat liver PPZC (A) was at 0.05 mu/ml with [“Plhistone, 
and PTP (w) in the Jurkat cell extract was at 0.15 mu/ml with 
[3ZP]RCM-lysozyme. 
examined. The activity resistant o 1 nM OA (Fig. 5; OA) was 
equivalent to that resistant o 100 PM TF23A (Fig. 5; T), and 
both could be suppressed to 10% activity by addition of 0.1 ,uM 
inhibitor 2 (Fig. 5; OA + I-2 and T + I-2). However, the activity 
resistant o 1 nM OA was not affected by addition of 100 ,uM 
TF23A (Fig. 5; OA+T). Thus 1 nM OA and 100 ,uM TF23A 
showed the same effect on the phosphatase activity, suggesting 
that TF23A specifically inhibits PP2A activity in the crude cell 
extract. Therefore, we reached the conclusion that the activity 
inhibited by 1 nM OA and that by 100 PM TF23A are identical 
and represent PP2A activity. 
Thus, we have shown here that TF23A is a specific inhibitor 
of PP2A activity. The IC,, value of TF23A was 105-lo6 fold 
higher than those of OA, microcystin-LR, and tautomycin. 
However, unlike those inhibitors, inhibitory effect of TF23A 
was specific for PP2A. These results indicate that TF23A is a 
novel useful probe not only to distinguish PP2A activity in a 
crude cell extracts, but also to identify physiological substrates 
of PP2A and analyse cellular processes that are regulated by 
PP2A. 
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Fig. 3. Effect of enzyme concentration on the inhibition of purified catalytic subunit of PPZA by TF23A. The catalytic subunit of PP2A was assayed 
at 0.005 mu/ml (m), 0.015 mu/ml (o), 0.05 mu/ml (0), and 0.15 mu/ml (A). The catalytic subunit of PPl (A) was assayed at 0.015 mu/ml. “P-Labelled 
MBP (A), histone (B), and phosphorylase a (C) were used as substrates. 
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Fig. 4. Effect of OA (A) and TF23A (B) on protein phosphatase activity in Jurkat cell extract. The activity was measured by using [‘*P]MBP as the 
substrate in the presence of indicated concentrations of the inhibitors at 50-fold dilution (15 &ml of protein) of the extract. 
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Fig. 5. The differential assay conditions for PPl and PP2A in Jurkat 
cell extract. Assay was carried out by using [‘*P]MBP at 50-fold dilution 
of the extract in the presence of 0.1 PM inhibitor-2 (I-2), 1 nM OA 
(OA), 100 PM TF23A (T), 1 nM OA plus 0.1 PM inhibitor-2 (OA + I- 
2), 100 PM TF23A plus 0.1 PM inhibitor-2 (T + I-2), 1 nM OA plus 
100 PM TF23A (OA + T), 50 mM NaF (NaF), or in their absence 
(none). 
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